Skip to content
Home/Companies/Biotech/Coave Therapeutics
Coave Therapeutics

Coave Therapeutics

Biotech·France·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns Coave Therapeutics?

Coave Therapeutics is currently owned by Go Capital through GO Capital (2021 vintage), since 2017. Across its history, Coave Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Go Capital
Most recent investor
Go Capital
GO Capital · 2021 · VC
3 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Turenne Groupe, Go Capital and Novo Holdings since 2015.
Co-invest · 3 holders · 2015 · present
Turenne Groupe
2015 · present(11yr) · Capital Santé 2 · 2020 · Growth
Go Capital
2017 · present(9yr) · GO Capital · 2021 · VC
Novo Holdings
2021 · present(5yr) · Novo Holdings Venture Investments · 1999 · VC
Track Coave Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Coave Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Coave Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue